Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Michael J. Farrell, a director at Resmed Inc, plans to sell 2,000 common shares through Merrill Lynch, valued at $500,000, on November 27, 2024. This sale follows recent transactions where Farrell sold over 24,000 shares of Resmed, Inc, amassing gross proceeds exceeding $6 million. Investors may find these insider transactions noteworthy as Farrell’s activities could impact market perceptions of Resmed’s stock.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ZMI, TBAL: 2 Canadian Balanced ETFs to Shield Your Returns
- Class Action Lawsuit Against Paragon 28, Inc. (NYSE:FNA)
- 3 Penny Stocks to Watch Now, 11/29/24
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
